While <i>PNPLA3</i> status did not independently predict ferritin levels, carriers had a significantly higher prevalence of hypertension (50.0% vs. 25.0%, <i>p</i> = 0.038) and a non-significant trend toward low HDL-C (65.0% vs. 42.9%, <i>p</i> = 0.070). Here, PNPLA3 is linked to hypertensive disorder.